Tuberculosis — Training Inmate Peer Educators in Detecting Tuberculosis in a Developing Country Prison: A Cluster Randomized Trial
Citation(s)
1 World Health Organization. Global tuberculosis report. Geneva, Switzerland 2014. 2. World Health Organization. Global tuberculosis report Geneva, Switzerland 2013. 3. 20202297 4. 17439681 5. 15971390 6. Reyes H. Pitfalls of TB management in prisons, revisited. International Journal of Prisoner Health. 2007;3(1):43-67. 7. 21251881 8. 9032218 9. 11419576 11. 17958984 12. 24498059 13. World Health Organization WH. Global tuberculosis report. 2013. 14. Ministry of Health of Ethiopia. Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme Manual. Addis Ababa 2008. 15. 20003219 16. 23241368 17. Tuberculosis Coalition for Technical Assistance and International Committee of the Red Cross. Guidelines for the control of tuberculosis in prisons. 2009. 18. 23241368 19. 25203007 20. 26914770 21. 9755959 22. Walmsley R, Britain G. World prison population list. Home Office London, England; 2003. 23. The Ethiopian Human Rights Commission. Human Rights Protection Monitoring in Ethiopian Prisons: Primary Report. Addis Ababa 2012. 24. The Federal Democratic Republic of Ethiopia. Guidelines for clinical and programmatic management of TB, TB/HIV and leprosy in Ethiopia. Addis Ababa, Ethiopia 2013. 25. World Health Organization. TB Case Definitions Revision 2011. 26. 10342698
Training Inmate Peer Educators in Detecting Tuberculosis in Prisons
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.